TMSB10 and Duchenne muscular dystrophy: Although many studies have supported that TMSB10 promotes macrophage M2 conversion and serves as a biomarker in cases with malignant tumors (Bouchal et al., 2015; Zeng et al., 2020; Yan et al., 2021), few studies have investigated its specific role in DMD cases.